Meta AnalysisID 173

短链脂肪酸对人类血糖控制的影响:一项系统评价和Meta分析

CRD42021231115

What is the effect of short chain fatty acids (SCFAs) (acetate, propionate and butyrate) on blood glucose and insulin levels in humans?

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Herb: 1Meta-analysis: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final meta_analysis record.

Meta Analysis Id
173
Evidence Id
8731
Core Evidence Id
8731
Source Meta Analysis Id
159
Herb2 Meta Analysis Id
HBMA000159
Crd Id
CRD42021231115
Title
The effect of short-chain fatty acids on glycaemic control in humans: a systematic review and meta-analysis
Review Question
What is the effect of short chain fatty acids (SCFAs) (acetate, propionate and butyrate) on blood glucose and insulin levels in humans?
Study Type Included
Interventional studies preferably randomised clinical trials and in controlled settings if acute.
Condition Being Studied
Glycaemic control (glucose and insulin) in humans.
Participant
Inclusion: humans (males or females), adults >=18 years old, any gender or ethnicity, and healthy lean, overweight or obese, have metabolic syndrome or type 2 diabetes. Exclusion: children, and having any other disease/syndrome that are not mentioned in the inclusion criteria such as liver disease, type 1 diabetes, etc.
Animal
Human Disease Modelled
Intervention
Inclusion: Vinegar, Acetate, Propionate and Butyrate administration alone, via routes of administration that include oral, intravenous and gastrointestinal. Administrations both lasting =<24h (acute) and >24h (chronic). Exclusion: SCFA conjugated with other substances that are not salts (i.e. hormones). SCFA combined with another type of fibre.
Comparator Control
Inclusion: against placebo Exclusion: When the comparison is done against different health status populations, for example, healthy vs. type 2 diabetic
Main Outcome
Quantifiable measures of glycaemic control as main outcomes such as fasting glucose/insulin, postprandial glucose/insulin (i.e. area under the curve), Hb1Ac, insulin sensitivity indexes (i.e. HOMA-IR, clamps). Measures of effect End of intervention values for test and control or change from baseline for test and control (depending on what is available).
Outcome Measure
Additional Outcome
None. Measures of effect Not applicable.
Study Method
Intervention, Meta-analysis, Narrative synthesis, Systematic review
Keyword
Blood Glucose; Fatty Acids; Fatty Acids, Volatile; Glycemic Control; Humans
Contact
Anna Cherta-Murillo [email protected]
Organisational Affiliation
Imperial College London https://www.imperial.ac.uk/nutrition-and-food-centre
Funding Source
Quorn Foods Ltd. Imperial College London. Ministry of Higher Education, United Arab Emirates. The Section for Nutrition Research, Department of Metabolism, Digestion and Reproduction is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7- HEALTH- 2009- 241592 EuroCHIP grant and is supported by the NIHR Biomedical Research Centre Funding Scheme.
Other Selection Criteria
Final Publication
Not yet
Same Topic Review
Published Protocol
Review Type
Language
English
Country
England
Review Stage
Review Completed not published
First Submission Date
2021-01-14
Registration Date
2021-01-25
Anticipated Start Date
2020-11-15
Anticipated Completion Date
2021-03-31
Title Cn
短链脂肪酸对人类血糖控制的影响:一项系统评价和Meta分析
Title En
The effect of short-chain fatty acids on glycaemic control in humans: a systematic review and meta-analysis
Bilingual Status
complete